Meeder Asset Management Inc Staar Surgical CO Transaction History

Meeder Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$70.55 - $111.58 $1,128 - $1,785	-16 Reduced 10.67%	134 $9,000
Q2 2022 Aug 08, 2022	SELL	$50.24 - $80.48 $60,036 - $96,173	-1,195 Reduced 88.85%	150 $11,000
Q1 2022 May 10, 2022	BUY	$57.98 - $93.5 $69,460 - $112,013	1,198 Added 814.97%	1,345 $107,000
Q4 2021 Feb 11, 2022	SELL	$88.02 - $127.79 $222,074 - $322,414	-2,523 Reduced 94.49%	147 $13,000
Q3 2021 Nov 08, 2021	BUY	$122.75 - $162.68 $29,337 - $38,880	239 Added 9.83%	2,670 $343,000
Q2 2021 Aug 09, 2021	BUY	$105.76 - $154.96 $140,660 - $206,096	1,330 Added 120.8%	2,431 $371,000
Q1 2021 Apr 28, 2021	BUY	$78.5 - $126.48 $86,428 - $139,254	1,101 New	1,101 $117,000
Q1 2019 Apr 16, 2019	SELL	$27.81 - $40.78 $33,038 - $48,446	-1,188 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$28.91 - $50.0 $1,763 - $3,050	-61 Reduced 4.88%	1,188 $37,000
Q3 2018 Nov 02, 2018	SELL	$30.85 - $50.65 $12,926 - $21,222	-419 Reduced 25.12%	1,249 $0
Q2 2018 Jul 24, 2018	BUY	$13.95 - $32.65 $21,706 - $50,803	1,556 Added 1389.29%	1,668 $0
Q4 2017 Feb 02, 2018	BUY	$12.45 - $17.4 $1,394 - $1,948	112	112 $2,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.